Comparative proteomic analyses of synovial fluids and serums from rheumatoid arthritis patients

Journal of Microbiology and Biotechnology

Volumn 24, Issue 1, 2014, Pages 119-126

  Noh, Ran ^a   Park, Sung Goo ^a   Ju, Ji Hyeon ^b   Chi, Seung Wook ^a   Kim, Sunhong ^a   Lee, Chong Kil ^c   Kim, Jeong Hoon ^a   Park, Byoung Chul ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Chungbuk National University   (South Korea)

Author keywords

Proteomic analyses; Rheumatoid arthritis; Serum; Synovial fluid

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 16; CYTOKERATIN 9; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN STEAP4; PROTEIN ZNF 658; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COMPARATIVE PROTEOMIC ANALYSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PATIENT MONITORING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; HUMANS; PROTEOME; PROTEOMICS; SERUM; SYNOVIAL FLUID;

EID: 84893084416     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1307.07046     Document Type: Article

References (27)

1. Castellino F, Zhong G, Germain RN. 1997. Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. Hum. Immunol. 54: 159-169.
2. Egerer K, Feist E, Burmester GR. 2009. The serological diagnosis of rheumatoid arthritis. Dtsch. Arztebl. Int. 106: 159-163.
3. Firestein GS. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
4. Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, et al. 2007. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res. Ther. 9: R36.
5. Hansen TH, Bouvier M. 2009. MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9: 503-513.
6. Hewitt EW. 2003. The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110: 163-169.
7. Inoue A, Matsumoto I, Tanaka Y, Iwanami K, Kanamori A, Ochiai N, et al. 2009. Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis. Arthritis Res. Ther. 11: R118.
8. Klareskog L, Rönnelid J, Lundberg K, Padyukov L, Alfredsson L. 2008. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26: 651-675.
9. Liao J, Ip WS, Cheung KY, Wan WM, Cautherley GW, Cai X, et al. 2011. Diagnostic utility of an anti-CCP point-of-care immunotest in Chinese patients with rheumatoid arthritis. Clin. Chim. Acta 412: 778-781.
10. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ. 2000. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43: 30-37.
11. Margaretten M, Julian L, Katz P, Yelin E. 2011. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int. J. Clin. Rheumtol. 6: 617-623.
12. Mateos J, Lourido L, Fernández-Puente P, Calamia V, Fernández-López C, Oreiro N, et al. 2012. Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J. Proteomics 75: 2869-2878.
13. McInnes IB, Schett G. 2011. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365: 2205-2219.
14. Miyake K, Nishida K, Kadota Y, Yamasaki H, Nasu T, Saitou D, et al. 2009. Inflammatory cytokine-induced expression of vasohibin-1 by rheumatoid synovial fibroblasts. Acta Med. Okayama 63: 349-358.
15. Purcell AW, Elliott T. 2008. Molecular machinations of the MHC-I peptide loading complex. Curr. Opin. Immunol. 20: 75-81.
16. Sato Y. 2010. The vasohibin family. Pharmaceuticals 3: 433-440.
17. Sato Y, Sonoda H. 2007. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27: 37-41.
18. Silman A, Pearson JE. 2002. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4(Suppl 3): S265-S272.
19. Sinz A, Bantscheff M, Mikkat S, Ringel B, Drynda S, Kekow J, et al. 2002. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 23: 3445-3456.
20. Steiner G, Smolen J. 2002. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res. 4(Suppl 2): S1-S5.
21. Suzuki A, Yamada R, Yamamoto K. 2007. Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann. NY Acad. Sci. 1108: 323-339.
22. Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Minami R, Umeda N, et al. 2012. Six-transmembrane epithelial antigen of prostate 4 (STEAP4) is a tumor necrosis factor alphainduced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis. Mod. Rheumatol. 22: 128-136.
23. Thibodeau J, Bourgeois-Daigneault MC, Lapointe R. 2012. Targeting the MHC class II antigen presentation pathway in cancer immunotherapy. Oncoimmunology 1: 908-916.
24. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. 2002. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 4: 87-93.
25. van Venrooij WJ, van Beers JJ, Pruijn GJ. 2008. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann. NY Acad. Sci. 1143: 268-285.
26. Vossenaar ER, van Venrooij WJ. 2004. Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis. Clin. Appl. Immunol. Rev. 4: 239-262.
27. Willemze A, Toes RE, Huizinga TW, Trouw LA. 2012. New biomarkers in rheumatoid arthritis. Neth. J. Med. 70: 392-399